Sword Health's latest publicly disclosed primary financing record is a USD 40,000,000 Venture Round dated June 17, 2025. The event is shown on the company page using the event date—not the date Captables published this historical profile.
General Catalyst is identified as lead investor.
The preceding primary records in the ledger are USD 30,000,000 Series E (Primary) dated June 2024; USD 163,000,000 Series D dated November 2021; USD 85,000,000 Series C dated June 2021. These entries describe disclosed company financings; they do not include every secondary trade, employee tender, valuation mark or rumored transaction unless those events are separately labeled in the company ledger.
Sword Health is ranked number 74 in the Captables Private 100 source universe. It operates in Digital Health and is based in United States. Its $4.00B ranking value is a third-party snapshot and should not be treated as a current executable share price or as the valuation for this round.
The round is currently supported by a public financing-database entry rather than an issuer filing, so Captables labels it as database-listed evidence. This page is a public-source reconstruction, not the issuer's stock ledger or legal capitalization table; undisclosed terms remain undisclosed and readers can submit stronger evidence for editorial review.